| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.961 | 0.001 | 0.961 | Bile acid receptor antagonist | 0.581 0.001 DBMET00553 | ||
| 0.958 | 0.001 | 0.958 | Phospholipase C inhibitor | 0.803 0.002 DBMET00553 | ||
| 0.949 | 0.001 | 0.967 | Cholesterol antagonist | 0.967 0.001 DBMET00553 | DBMET00553 | |
| 0.916 | 0.001 | 0.916 | Sodium/bile acid cotransporter inhibitor | 0.641 0.001 DBMET00553 | ||
| 0.843 | 0.006 | 0.863 | Caspase 9 stimulant | 0.863 0.004 DBMET00553 | DBMET00553 | |
| 0.844 | 0.01 | 0.89 | Antiinflammatory | 0.89 0.005 DBMET00553 | DBMET00553 | |
| 0.811 | 0.002 | 0.811 | Anesthetic general | 0.789 0.003 DBMET00553 | ||
| 0.765 | 0.009 | 0.853 | Cyclophilin D inhibitor | 0.853 0.005 DBMET00553 | DBMET00553 | |
| 0.774 | 0.02 | 0.805 | Apoptosis agonist | 0.805 0.016 DBMET00553 | DBMET00553 | |
| 0.719 | 0.018 | 0.9 | Transcription factor NF kappa B inhibitor | 0.9 0.006 DBMET00553 | DBMET00553 | |
| 0.695 | 0.004 | 0.703 | Apoptosis antagonist | 0.703 0.004 DBMET00553 | DBMET00553 | |
| 0.692 | 0.005 | 0.692 | Hypolipemic | 0.62 0.005 DBMET00553 | ||
| 0.688 | 0.001 | 0.688 | Cholesterol synthesis inhibitor | 0.519 0.002 DBMET00553 | ||
| 0.678 | 0.001 | 0.678 | Lipocortins synthesis antagonist | 0.593 0.002 DBMET00553 | ||
| 0.675 | 0.013 | 0.675 | Antiobesity | 0.634 0.017 DBMET00553 | ||
| 0.647 | 0.001 | 0.647 | Farnesoid X receptor agonist | 0.239 0.002 DBMET00553 | ||
| 0.63 | 0.005 | 0.844 | Angiogenesis stimulant | 0.844 0.003 DBMET00553 | DBMET00553 | |
| 0.622 | 0.004 | 0.7 | Hepatoprotectant | 0.7 0.004 DBMET00553 | DBMET00553 | |
| 0.605 | 0.002 | 0.605 | Farnesoid X receptor antagonist | 0.412 0.003 DBMET00553 | ||
| 0.604 | 0.003 | 0.604 | Androgen antagonist | 0.141 0.025 DBMET00553 | ||
| 0.598 | 0.003 | 0.841 | Expectorant | 0.841 0.001 DBMET00553 | DBMET00553 | |
| 0.567 | 0.001 | 0.567 | 5-Alpha-reductase inhibitor | 0.398 0.002 DBMET00553 | ||
| 0.579 | 0.016 | 0.601 | Immunosuppressant | 0.601 0.013 DBMET00553 | DBMET00553 | |
| 0.563 | 0.021 | 0.713 | Immunostimulant | 0.713 0.007 DBMET00553 | DBMET00553 | |
| 0.566 | 0.025 | 0.734 | Antibacterial | 0.734 0.006 DBMET00553 | DBMET00553 | |
| 0.549 | 0.013 | 0.627 | Nitric oxide antagonist | 0.627 0.008 DBMET00553 | DBMET00553 | |
| 0.542 | 0.011 | 0.558 | DNA damaging | 0.558 0.01 DBMET00553 | DBMET00553 | |
| 0.517 | 0.005 | 0.567 | Interferon gamma antagonist | 0.567 0.003 DBMET00553 | DBMET00553 | |
| 0.494 | 0.002 | 0.494 | Mucolytic | 0.448 0.003 DBMET00553 | ||
| 0.481 | 0.008 | 0.646 | Diuretic | 0.646 0.004 DBMET00553 | DBMET00553 | |
| 0.473 | 0.003 | 0.473 | Pregnane X receptor agonist | 0.135 0.085 DBMET00553 | ||
| 0.471 | 0.005 | 0.607 | Alkylator | 0.607 0.004 DBMET00553 | DBMET00553 | |
| 0.458 | 0.012 | 0.589 | Interleukin agonist | 0.589 0.005 DBMET00553 | DBMET00553 | |
| 0.477 | 0.032 | 0.783 | Antithrombotic | 0.783 0.005 DBMET00553 | DBMET00553 | |
| 0.445 | 0.012 | 0.445 | P-glycoprotein inhibitor | 0.353 0.021 DBMET00553 | ||
| 0.413 | 0.001 | 0.413 | 5-Alpha-reductase 2 inhibitor | 0.192 0.003 DBMET00553 | ||
| 0.431 | 0.019 | 0.459 | Interleukin 2 agonist | 0.459 0.014 DBMET00553 | DBMET00553 | |
| 0.405 | 0.002 | 0.405 | Botulinum neurotoxin type A inhibitor | 0.063 0.033 DBMET00553 | ||
| 0.426 | 0.024 | 0.45 | Hypoxia-inducible factor 1 alpha inhibitor | 0.45 0.02 DBMET00553 | DBMET00553 | |
| 0.431 | 0.03 | 0.617 | Antioxidant | 0.617 0.01 DBMET00553 | DBMET00553 | |
| 0.41 | 0.026 | 0.631 | Hypoglycemic | 0.631 0.007 DBMET00553 | DBMET00553 | |
| 0.422 | 0.038 | 0.44 | Caspase 3 stimulant | 0.44 0.032 DBMET00553 | DBMET00553 | |
| 0.382 | 0.002 | 0.382 | 5-Alpha-reductase 1 inhibitor | 0.069 0.006 DBMET00553 | ||
| 0.389 | 0.017 | 0.389 | Growth hormone agonist | 0.218 0.052 DBMET00553 | ||
| 0.378 | 0.01 | 0.437 | Protein kinase stimulant | 0.437 0.006 DBMET00553 | DBMET00553 | |
| 0.37 | 0.004 | 0.37 | Estrogen receptor alpha antagonist | |||
| 0.363 | 0.008 | 0.363 | DNA polymerase I inhibitor | 0.308 0.01 DBMET00553 | ||
| 0.362 | 0.017 | 0.479 | Platelet adhesion inhibitor | 0.479 0.006 DBMET00553 | DBMET00553 | |
| 0.339 | 0.009 | 0.429 | Insulin secretagoues | 0.429 0.005 DBMET00553 | DBMET00553 | |
| 0.335 | 0.009 | 0.335 | Aldehyde dehydrogenase inhibitor | 0.238 0.02 DBMET00553 | ||
| 0.36 | 0.036 | 0.409 | Platelet antagonist | 0.409 0.025 DBMET00553 | DBMET00553 | |
| 0.334 | 0.01 | 0.334 | Growth factor agonist | 0.258 0.028 DBMET00553 | ||
| 0.326 | 0.003 | 0.326 | Androgen agonist | 0.103 0.014 DBMET00553 | ||
| 0.383 | 0.061 | 0.383 | Vasodilator, peripheral | 0.35 0.074 DBMET00553 | ||
| 0.324 | 0.003 | 0.324 | CDC25A inhibitor | 0.225 0.005 DBMET00553 | ||
| 0.318 | 0.001 | 0.318 | Arachidonic acid antagonist | 0.26 0.004 DBMET00553 | ||
| 0.357 | 0.045 | 0.357 | Calcium channel activator | |||
| 0.305 | 0 | 0.305 | Ileal bile acid transport inhibitor | 0.3 0 DBMET00553 | ||
| 0.348 | 0.06 | 0.481 | Immunomodulator | 0.481 0.026 DBMET00553 | DBMET00553 | |
| 0.29 | 0.003 | 0.29 | Carbonic anhydrase IV inhibitor | 0.078 0.011 DBMET00553 | ||
| 0.302 | 0.014 | 0.302 | Antipruritic | 0.176 0.068 DBMET00553 | ||
| 0.278 | 0.001 | 0.429 | Na+ K+ transporting ATPase inhibitor | 0.429 0.001 DBMET00553 | DBMET00553 | |
| 0.294 | 0.02 | 0.294 | Neurotrophic factor enhancer | 0.236 0.047 DBMET00553 | ||
| 0.298 | 0.034 | 0.298 | Gastrin inhibitor | 0.253 0.076 DBMET00553 | ||
| 0.262 | 0.004 | 0.262 | Progesterone antagonist | |||
| 0.259 | 0.006 | 0.261 | Microtubule formation inhibitor | 0.261 0.006 DBMET00553 | DBMET00553 | |
| 0.264 | 0.014 | 0.264 | Protein-tyrosine phosphatase 1B inhibitor | 0.242 0.018 DBMET00553 | ||
| 0.255 | 0.006 | 0.577 | AMP-activated protein kinase stimulant | 0.577 0.003 DBMET00553 | DBMET00553 | |
| 0.252 | 0.006 | 0.252 | ABCA1 expression enhancer | 0.123 0.028 DBMET00553 | ||
| 0.253 | 0.008 | 0.253 | Estrogen antagonist | 0.146 0.025 DBMET00553 | ||
| 0.246 | 0.002 | 0.246 | RNA-directed RNA polymerase stimulant | 0.129 0.005 DBMET00553 | ||
| 0.266 | 0.027 | 0.266 | Protein-tyrosine phosphatase inhibitor | 0.233 0.035 DBMET00553 | ||
| 0.238 | 0.004 | 0.238 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.238 | 0.005 | 0.238 | Adenylate cyclase stimulant | 0.177 0.028 DBMET00553 | ||
| 0.259 | 0.026 | 0.418 | Amylase inhibitor | 0.418 0.008 DBMET00553 | DBMET00553 | |
| 0.236 | 0.003 | 0.236 | Glycine receptor agonist | 0.169 0.005 DBMET00553 | ||
| 0.233 | 0.002 | 0.233 | Anabolic | 0.166 0.011 DBMET00553 | ||
| 0.243 | 0.013 | 0.243 | Neurotrophic factor | 0.191 0.032 DBMET00553 | ||
| 0.233 | 0.007 | 0.233 | Estrogen agonist | 0.16 0.01 DBMET00553 | ||
| 0.28 | 0.065 | 0.28 | Cardiotonic | 0.197 0.121 DBMET00553 | ||
| 0.247 | 0.036 | 0.247 | Insulin sensitizer | 0.187 0.088 DBMET00553 | ||
| 0.237 | 0.027 | 0.237 | Phospholipase A2 inhibitor | 0.23 0.029 DBMET00553 | ||
| 0.204 | 0.004 | 0.204 | Liver X receptor alpha agonist | |||
| 0.197 | 0.003 | 0.197 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.185 0.003 DBMET00553 | ||
| 0.222 | 0.03 | 0.315 | Interleukin 6 antagonist | 0.315 0.013 DBMET00553 | DBMET00553 | |
| 0.243 | 0.054 | 0.243 | RNA-directed DNA polymerase inhibitor | 0.228 0.066 DBMET00553 | ||
| 0.219 | 0.031 | 0.219 | Bone formation stimulant | 0.162 0.051 DBMET00553 | ||
| 0.188 | 0.004 | 0.188 | Glucocorticoid antagonist | 0.095 0.005 DBMET00553 | ||
| 0.188 | 0.004 | 0.206 | Glycine receptor antagonist | 0.206 0.003 DBMET00553 | DBMET00553 | |
| 0.198 | 0.014 | 0.198 | Antineoplastic alkaloid | 0.094 0.052 DBMET00553 | ||
| 0.246 | 0.069 | 0.342 | DNA synthesis inhibitor | 0.342 0.032 DBMET00553 | DBMET00553 | |
| 0.187 | 0.011 | 0.187 | Prolactin inhibitor | |||
| 0.174 | 0.002 | 0.174 | Phospholipase D inhibitor | 0.132 0.004 DBMET00553 | ||
| 0.196 | 0.026 | 0.338 | Cell adhesion inhibitor | 0.338 0.008 DBMET00553 | DBMET00553 | |
| 0.179 | 0.011 | 0.179 | Estrogen receptor beta antagonist | 0.104 0.057 DBMET00553 | ||
| 0.244 | 0.077 | 0.452 | Tumour necrosis factor alpha release inhibitor | 0.452 0.019 DBMET00553 | DBMET00553 | |
| 0.165 | 0.001 | 0.165 | Vitamin D receptor agonist | 0.075 0.002 DBMET00553 | ||
| 0.17 | 0.006 | 0.181 | Phosphorylase inhibitor | 0.181 0.006 DBMET00553 | DBMET00553 | |
| 0.234 | 0.076 | 0.464 | Free radical scavenger | 0.464 0.02 DBMET00553 | DBMET00553 | |
| 0.157 | 0.004 | 0.157 | Diacylglycerol O-acyltransferase inhibitor | 0.065 0.022 DBMET00553 | ||
| 0.155 | 0.003 | 0.155 | Vitamin D receptor antagonist | 0.064 0.004 DBMET00553 | ||
| 0.158 | 0.012 | 0.158 | Aromatase inhibitor | |||
| 0.164 | 0.019 | 0.164 | Hedgehog signaling inhibitor | |||
| 0.169 | 0.027 | 0.269 | Antineoplastic antibiotic | 0.269 0.012 DBMET00553 | DBMET00553 | |
| 0.216 | 0.077 | 0.216 | EphB2 antagonist | |||
| 0.18 | 0.05 | 0.258 | NOS3 expression enhancer | 0.258 0.025 DBMET00553 | DBMET00553 | |
| 0.13 | 0.001 | 0.13 | Hedgehog signaling activator | 0.034 0.008 DBMET00553 | ||
| 0.143 | 0.017 | 0.202 | Transcription factor NF kappa B stimulant | 0.202 0.009 DBMET00553 | DBMET00553 | |
| 0.128 | 0.003 | 0.128 | Lipocortins synthesis agonist | 0.118 0.003 DBMET00553 | ||
| 0.118 | 0.011 | 0.118 | CDC25B inhibitor | 0.072 0.036 DBMET00553 | ||
| 0.116 | 0.01 | 0.116 | Caspase 9 inhibitor | 0.065 0.038 DBMET00553 | ||
| 0.114 | 0.01 | 0.114 | Estrogen receptor beta agonist | 0.065 0.017 DBMET00553 | ||
| 0.105 | 0.008 | 0.105 | Estrogen receptor alpha agonist | 0.034 0.024 DBMET00553 | ||
| 0.104 | 0.008 | 0.104 | Mineralocorticoid receptor antagonist | 0.048 0.034 DBMET00553 | ||
| 0.099 | 0.003 | 0.099 | Glucose-6-phosphate dehydrogenase inhibitor | 0.061 0.007 DBMET00553 | ||
| 0.097 | 0.004 | 0.097 | Parathyroid hormone antagonist | 0.059 0.012 DBMET00553 | ||
| 0.097 | 0.004 | 0.519 | Heparanase inhibitor | 0.519 0.001 DBMET00553 | DBMET00553 | |
| 0.143 | 0.055 | 0.289 | Cyclooxygenase 3 inhibitor | 0.289 0.006 DBMET00553 | DBMET00553 | |
| 0.099 | 0.012 | 0.099 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.139 | 0.053 | 0.139 | Adenylate cyclase inhibitor | |||
| 0.096 | 0.014 | 0.096 | Autotaxin inhibitor | |||
| 0.09 | 0.009 | 0.09 | Liver X receptor agonist | |||
| 0.084 | 0.003 | 0.084 | HMG CoA reductase inhibitor | 0.056 0.005 DBMET00553 | ||
| 0.085 | 0.005 | 0.085 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.104 | 0.026 | 0.34 | Selectin antagonist | 0.34 0.004 DBMET00553 | DBMET00553 | |
| 0.101 | 0.024 | 0.101 | Estrogen-related receptor beta agonist | |||
| 0.084 | 0.009 | 0.084 | Acetyl-CoA transferase 2 inhibitor | 0.061 0.029 DBMET00553 | ||
| 0.089 | 0.016 | 0.089 | Glutamate (mGluR6) antagonist | |||
| 0.09 | 0.022 | 0.09 | Carbonic anhydrase II inhibitor | 0.082 0.024 DBMET00553 | ||
| 0.102 | 0.035 | 0.102 | Inducible nitric-oxide synthase inhibitor | |||
| 0.072 | 0.005 | 0.072 | Microtubule stabilization | 0.069 0.007 DBMET00553 | ||
| 0.086 | 0.019 | 0.086 | Prostaglandin F2 alpha antagonist | |||
| 0.115 | 0.049 | 0.152 | Toll-Like receptor 4 antagonist | 0.152 0.02 DBMET00553 | DBMET00553 | |
| 0.092 | 0.026 | 0.092 | HIV-1 integrase (Strand Transfer) inhibitor | 0.071 0.035 DBMET00553 | ||
| 0.149 | 0.083 | 0.211 | Melanin inhibitor | 0.211 0.037 DBMET00553 | DBMET00553 | |
| 0.068 | 0.004 | 0.068 | Ceramide glucosyltransferase inhibitor | 0.056 0.005 DBMET00553 | ||
| 0.08 | 0.022 | 0.085 | Nitric oxide donor | 0.085 0.018 DBMET00553 | DBMET00553 | |
| 0.088 | 0.032 | 0.088 | Carbonic anhydrase inhibitor | 0.085 0.032 DBMET00553 | ||
| 0.086 | 0.031 | 0.086 | GABA B receptor agonist | |||
| 0.079 | 0.025 | 0.079 | Carbonic anhydrase I inhibitor | 0.075 0.027 DBMET00553 | ||
| 0.072 | 0.022 | 0.072 | Heme oxygenase stimulant | 0.06 0.046 DBMET00553 | ||
| 0.063 | 0.017 | 0.063 | Aldosterone antagonist | |||
| 0.11 | 0.064 | 0.11 | Chelator | |||
| 0.172 | 0.13 | 0.299 | Vasodilator | 0.299 0.048 DBMET00553 | DBMET00553 | |
| 0.135 | 0.094 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.13 0.121 DBMET00553 | ||
| 0.047 | 0.005 | 0.047 | CYP24 inhibitor | |||
| 0.127 | 0.087 | 0.241 | Lipid peroxidase inhibitor | 0.241 0.029 DBMET00553 | DBMET00553 | |
| 0.102 | 0.065 | 0.102 | GABA C receptor agonist | |||
| 0.091 | 0.055 | 0.091 | Ornithine decarboxylase inhibitor | |||
| 0.081 | 0.047 | 0.081 | Keratolytic | |||
| 0.047 | 0.012 | 0.047 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.038 | 0.004 | 0.038 | Corticosteroid-like | 0.035 0.005 DBMET00553 | ||
| 0.131 | 0.098 | 0.288 | Thrombolytic | 0.288 0.026 DBMET00553 | DBMET00553 | |
| 0.061 | 0.029 | 0.061 | Acetyl-CoA transferase inhibitor | |||
| 0.046 | 0.015 | 0.046 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.037 | 0.006 | 0.037 | Prostaglandin F2 alpha agonist | |||
| 0.149 | 0.119 | 0.149 | Interleukin antagonist | |||
| 0.04 | 0.01 | 0.04 | Glutamate (mGluR3) agonist | |||
| 0.059 | 0.032 | 0.118 | Protein 50S ribosomal subunit inhibitor | 0.118 0.01 DBMET00553 | DBMET00553 | |
| 0.04 | 0.013 | 0.04 | Prostaglandin D2 agonist | |||
| 0.059 | 0.032 | 0.059 | Pregnane X receptor antagonist | |||
| 0.032 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | |||
| 0.032 | 0.006 | 0.032 | Glucocorticoid agonist | |||
| 0.171 | 0.145 | 0.349 | Peptidyltransferase inhibitor | 0.349 0.012 DBMET00553 | DBMET00553 | |
| 0.158 | 0.132 | 0.158 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.049 | 0.024 | 0.049 | AICAR transformylase inhibitor | |||
| 0.17 | 0.145 | 0.256 | Spasmolytic | 0.256 0.088 DBMET00553 | DBMET00553 | |
| 0.028 | 0.004 | 0.028 | Thromboxane A2 agonist | |||
| 0.117 | 0.094 | 0.117 | Vanilloid 1 agonist | 0.115 0.101 DBMET00553 | ||
| 0.026 | 0.004 | 0.036 | Telomerase stimulant | 0.036 0.002 DBMET00553 | DBMET00553 | |
| 0.046 | 0.024 | 0.046 | GABA B receptor antagonist | |||
| 0.024 | 0.003 | 0.024 | Thromboxane agonist | |||
| 0.081 | 0.061 | 0.081 | T cell inhibitor | 0.08 0.067 DBMET00553 | ||
| 0.038 | 0.018 | 0.038 | Tubulin agonist | |||
| 0.043 | 0.023 | 0.043 | GABA uptake inhibitor | |||
| 0.07 | 0.053 | 0.07 | Epoxide hydrolase inhibitor | |||
| 0.143 | 0.126 | 0.283 | Non-steroidal antiinflammatory agent | 0.283 0.032 DBMET00553 | DBMET00553 | |
| 0.017 | 0.001 | 0.017 | Transcortin receptor antagonist | |||
| 0.045 | 0.029 | 0.045 | Geranyltranstransferase inhibitor | |||
| 0.021 | 0.008 | 0.021 | Sodium/hydrogen exchanger inhibitor | |||
| 0.021 | 0.008 | 0.021 | Prostacyclin agonist | |||
| 0.016 | 0.004 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.012 0.01 DBMET00553 | ||
| 0.033 | 0.022 | 0.033 | Carboxypeptidase B inhibitor | |||
| 0.021 | 0.01 | 0.021 | Progesterone agonist | |||
| 0.046 | 0.036 | 0.048 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.033 DBMET00553 | DBMET00553 | |
| 0.029 | 0.024 | 0.029 | Prostaglandin agonist | |||
| 0.102 | 0.098 | 0.102 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.146 | 0.142 | 0.146 | Aldehyde oxidase inhibitor | |||
| 0.005 | 0.002 | 0.005 | Vitamin D-like | |||
| 0.033 | 0.032 | 0.033 | Glutamate (mGluR3) antagonist | |||
| 0.028 | 0.027 | 0.028 | Cholesterol ester transfer protein antagonist | |||
| 0.058 | 0.059 | 0.104 | Phosphofructokinase-1 inhibitor | 0.104 0.03 DBMET00553 | DBMET00553 | |
| 0.077 | 0.082 | 0.093 | Triose-phosphate isomerase inhibitor | 0.093 0.055 DBMET00553 | DBMET00553 | |
| 0.025 | 0.032 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 DBMET00553 | DBMET00553 | |
| 0.074 | 0.095 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.042 DBMET00553 | DBMET00553 | |
| 0.004 | 0.027 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 DBMET00553 | DBMET00553 | |
| 0.126 | 0.154 | 0.217 | ATPase inhibitor | 0.217 0.026 DBMET00553 | DBMET00553 | |
| 0.04 | 0.07 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET00553 | DBMET00553 | |
| 0.077 | 0.11 | 0.108 | Interleukin 12 antagonist | 0.108 0.042 DBMET00553 | DBMET00553 | |
| 0.028 | 0.071 | 0.051 | Mannosidase inhibitor | 0.051 0.024 DBMET00553 | DBMET00553 | |
| 0.083 | 0.13 | 0.104 | Photosensitizer | 0.104 0.081 DBMET00553 | DBMET00553 | |
| 0.016 | 0.064 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 DBMET00553 | DBMET00553 | |
| 0.072 | 0.126 | 0.086 | Glutamate release inhibitor | 0.086 0.072 DBMET00553 | DBMET00553 | |
| 0.076 | 0.13 | 0.14 | Beta amyloid protein antagonist | 0.14 0.048 DBMET00553 | DBMET00553 | |
| 0.018 | 0.094 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 DBMET00553 | DBMET00553 | |
| 0.012 | 0.093 | 0.041 | Protein 30S ribosomal subunit inhibitor | 0.041 0.01 DBMET00553 | DBMET00553 | |
| 0.046 | 0.139 | 0.14 | Monophenol monooxygenase inhibitor | 0.14 0.051 DBMET00553 | DBMET00553 | |
| 0.045 | 0.156 | 0.163 | Topoisomerase I inhibitor | 0.163 0.037 DBMET00553 | DBMET00553 | |
| 0.02 | 0.133 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.007 DBMET00553 | DBMET00553 | |
| 0.045 | 0.201 | 0.084 | Uric acid excretion stimulant | 0.084 0.076 DBMET00553 | DBMET00553 | |
| 0.112 | 0.329 | 0.218 | Vasodilator, coronary | 0.218 0.166 DBMET00553 | DBMET00553 | |
| 0.021 | 0.254 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.031 DBMET00553 | DBMET00553 | |
| 0.067 | 0.319 | 0.232 | Hemostatic | 0.232 0.024 DBMET00553 | DBMET00553 | |
| 0.047 | 0.312 | 0.183 | Anticoagulant | 0.183 0.06 DBMET00553 | DBMET00553 | |
| 0.043 | 0.353 | 0.15 | Cell wall synthesis inhibitor | 0.15 0.065 DBMET00553 | DBMET00553 | |
| 0.098 | 0.411 | 0.302 | Histamine release inhibitor | 0.302 0.122 DBMET00553 | DBMET00553 | |
| 0.086 | 0.452 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.061 DBMET00553 | DBMET00553 | |
| 0.016 | 0.41 | 0.077 | Topoisomerase II alpha inhibitor | 0.077 0.056 DBMET00553 | DBMET00553 | |
| 0.02 | 0.416 | 0.125 | Topoisomerase II inhibitor | 0.125 0.063 DBMET00553 | DBMET00553 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |